He, Zelai <br/><br/>
Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.  [electronic resource] 

 -  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine  Jun 2016 
 - 7809-21 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1423-0380 
<br/><br/><label>Standard No.: </label>10.1007/s13277-015-4634-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Apoptosis--drug effects<br/>Blood--drug effects<br/>Blood Coagulation--drug effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line<br/>Cisplatin--administration & dosage<br/>Complement Activation--drug effects<br/>Drug Carriers<br/>Drug Compounding<br/>Folic Acid--administration & dosage<br/>Hemolysis--drug effects<br/>Humans<br/>Leukocyte Count<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Nanoparticles--administration & dosage<br/>Paclitaxel--administration & dosage<br/>Polyesters--administration & dosage<br/>Polyethylene Glycols--administration & dosage<br/>Rabbits<br/>Xenograft Model Antitumor Assays